Resultados de la búsqueda

Salvadó G, Janelidze S, Bali D, Dolado AO, Therriault J, Brum WS, Pichet Binette A, Stomrud E, Mattsson-Carlgren N, Palmqvist S, Coomans EM, Teunissen CE, van der Flier WM, Rahmouni N, Benzinger TLS, Gispert JD, Blennow K, Doré V, Feizpour A, Rowe CC, Alcolea D, Fortea J, Villeneuve S, Johnson SC, Rosa-Neto P, Petersen RC, Jack CR Jr, Schindler SE, Suárez-Calvet M, Ossenkoppele R, Hansson O; ADNI, ALFA, and PREVENT-AD Study Groups. lasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease. JAMA Neurol (2025) :e253217

Crespo-Leiro MG, Hanna M, Damy T, Delgado D, Ebede B, Marino V, Wang R, Maurer MS, Garcia-Pavia P, Drachman BM. arly Access to Tafamidis for Patients With Transthyretin Amyloid Cardiomyopathy. JACC Adv (2025) 4:102122

Ryan T, Morillo CA, Jalife J. The Complex Interplay Between Aging, Cardiac Remodeling, and Atrial Fibrillation. JACC Clin Electrophysiol (2025) Nov 7 [Epub ahead of print]

Bernal A, Hamid A, Grao-Roldán C, Scarpa A, Sánchez I, Nicolás-Ávila JÁ, Pena-Couso L, Yaghmour MH, Benguría A, Rosado A, Sánchez-García L, Torroja C, Dopazo A, Sánchez-Cabo F, Hidalgo A, Senders ML, van Leent MMT, Seep L, Hasenauer J, Placek K, Thiele C, Netea MG, Mulder WJM, Riksen NP, Pérez-Medina C. HDL-associated phosphatidylserine blunts myeloid activation and protects from atherosclerosis. bioRxiv [Preprint]. bioRxiv (2025) Nov 30 [Epub ahead of print]
bioRxiv [Preprint]

Pascual-Figal DA, Fuster JJ. Clonal Hematopoiesis-An Opportunity to Confront the Heart Failure Epidemic. JAMA Cardiol (2025) Nov 9 [Epub ahead of print]
Link to the full text in Repisalud

Martín P. Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis. JACC CardioOncol (2025) 7:578-579
Link to the full text in Repisalud

Gillmore JD, Judge DP, Cappelli F, Fontana M, Garcia-Pavia P, Gibbs S, Grogan M, Hanna M, Hoffman J, Masri A, Maurer MS, Nativi-Nicolau J, Obici L, Poulsen SH, Rockhold F, Shah KB, Soman P, Garg J, Chiswell K, Xu H, Cao X, Lystig T, Sinha U, Fox JC; ATTRibute-CM Investigators. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy. N Engl J Med (2024) 390:132-142.

Maron MS, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA-HCM Investigators. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy. N Engl J Med (2024) 390:1849-1861.

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS; HELIOS-B Trial Investigators. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. N Engl J Med (2024) 392:33-44.

Ng MSF, Kwok I, Tan L, Shi C, Cerezo-Wallis D, Tan Y, Leong K, Calvo GF, Yang K, Zhang Y, Jin J, Liong KH, Wu D, He R, Liu D, Teh YC, Bleriot C, Caronni N, Liu Z, Duan K, Narang V, Ballesteros I, Moalli F, Li M, Chen J, Liu Y, Liu L, Qi J, Liu Y, Jiang L, Shen B, Cheng H, Cheng T, Angeli V, Sharma A, Loh YH, Tey HL, Chong SZ, Iannacone M, Ostuni R, Hidalgo A, Ginhoux F, Ng LG. Deterministic reprogramming of neutrophils within tumors. Science (2024) 383:eadf6493
Link to the full text in Repisalud